CN Stock MarketDetailed Quotes
301093 Jiangsu Hualan New Pharmaceutical Material
- 23.05
- +0.10+0.44%
Market Closed Dec 27 15:00 CST
2.93BMarket Cap36.24P/E (TTM)
23.21High22.83Low10.59KlotVolume23.21Open22.95Pre Close24.35MTurnover1.20%Turnover Ratio24.84P/E (Static)127.08MShares31.9452wk High1.34P/B2.04BFloat Cap17.1252wk Low27.54Limit Up88.29MShs Float56.28Historical High18.36Limit Down1.66%Amplitude17.12Historical Low0.60Dividend TTM23.00Avg Price5.57KlotAsk2.60%Div YieldTTM100Lot Size4.93KlotBid
Jiangsu Hualan New Pharmaceutical Material Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -6.82%422.8M | -6.33%283.74M | -19.05%126.56M | 6.64%622.92M | 11.42%453.75M | 12.93%302.91M | 19.42%156.34M | -28.84%584.14M | -36.61%407.25M | -32.60%268.23M |
| Operating revenue | -6.82%422.8M | -6.33%283.74M | -19.05%126.56M | 6.64%622.92M | 11.42%453.75M | 12.93%302.91M | 19.42%156.34M | -28.84%584.14M | -36.61%407.25M | -32.60%268.23M |
| Other operating revenue | ---- | 185.87%1.03M | ---- | 117.92%1.03M | ---- | -46.61%359.98K | ---- | -70.48%471.42K | ---- | 5.46%674.19K |
| Total operating cost | -4.39%380.15M | -2.28%256.59M | -7.36%123.65M | 8.34%550.22M | 15.25%397.63M | 17.38%262.58M | 25.75%133.47M | -10.12%507.87M | -17.50%345.02M | -14.79%223.7M |
| Operating cost | -0.79%257.27M | 1.83%171.93M | -9.73%78.79M | 10.43%363.63M | 11.38%259.32M | 13.79%168.84M | 22.52%87.28M | -10.62%329.29M | -16.17%232.82M | -14.45%148.37M |
| Operating tax surcharges | 12.45%5.1M | 16.22%3.33M | 9.27%1.29M | 3.57%6.36M | 16.07%4.54M | -0.92%2.87M | 9.83%1.18M | -31.11%6.14M | -48.42%3.91M | -37.20%2.89M |
| Operating expense | -14.01%36.23M | -11.73%27.06M | -25.74%9.98M | 4.92%55.41M | 4.48%42.13M | 11.86%30.66M | 18.17%13.44M | -27.24%52.81M | -24.39%40.33M | -17.47%27.41M |
| Administration expense | -17.35%56.06M | -16.44%36.78M | 7.49%23.44M | 4.07%92.6M | 41.41%67.83M | 40.22%44.02M | 30.83%21.81M | 24.59%88.97M | 5.68%47.97M | 12.51%31.39M |
| Financial expense | -125.75%-3.39M | -79.68%-2.27M | -185.90%-948.74K | 34.29%-3.96M | 74.91%-1.5M | 66.81%-1.27M | 131.95%1.1M | -457.22%-6.02M | -218.99%-5.99M | -187.22%-3.81M |
| -Interest expense (Financial expense) | -62.61%164.19K | -63.22%98.44K | -99.39%1.23K | -26.71%439.26K | -26.74%439.09K | -43.91%267.64K | 122.68%202.79K | -87.59%599.38K | -85.88%599.38K | -85.11%477.12K |
| -Interest Income (Financial expense) | -169.84%-4.25M | -252.95%-3.75M | -287.86%-1.78M | 50.65%-2.84M | 70.65%-1.57M | 75.04%-1.06M | 86.80%-458.07K | -54.08%-5.76M | -3,022.91%-5.36M | -4,085.57%-4.26M |
| Research and development | 14.09%28.89M | 13.11%19.76M | 28.20%11.1M | -1.37%36.18M | -2.57%25.32M | 0.11%17.47M | -6.29%8.66M | -12.82%36.69M | -10.86%25.99M | -8.21%17.45M |
| Credit Impairment Loss | -88.38%239.66K | -83.09%342.66K | 10.74%935.58K | 180.56%1.02M | 139.86%2.06M | 156.92%2.03M | -36.41%844.88K | 46.97%-1.26M | 120.00%859.69K | 115.47%788.57K |
| Asset Impairment Loss | -154.04%-3.21M | -36.63%-531.77K | -845.02%-166.58K | 55.39%-1.05M | -155.80%-1.26M | -6.86%-389.2K | 129.85%22.36K | 17.30%-2.36M | -402.06%-493.25K | 62.07%-364.21K |
| Other net revenue | -58.43%20.92M | -48.33%15.96M | -40.32%9.59M | 88.71%65.99M | 63.70%50.32M | 41.97%30.88M | 33.20%16.07M | 2,217.19%34.97M | 2,587.09%30.74M | 512.41%21.75M |
| Fair value change income | 9.48%3.88M | 27.59%3.01M | -2.60%1.42M | -87.38%3.26M | -80.55%3.54M | -83.86%2.36M | -82.80%1.46M | --25.83M | --18.21M | --14.62M |
| Invest income | -44.74%13.34M | -49.29%8.95M | -19.68%5.61M | 396.79%45.36M | 124.12%24.13M | 219.33%17.66M | 296.11%6.98M | --9.13M | --10.77M | --5.53M |
| Net open hedge income | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Asset deal income | -98.42%777.23 | -84.70%7.52K | -6,184.17%-247.02K | -9.51%214.45K | 107.09%49.17K | 143.26%49.15K | 6,766.68%4.06K | 15,245.79%237K | ---693.41K | --20.2K |
| Other revenue | -69.39%6.67M | -54.52%4.17M | -69.86%2.04M | 406.64%17.19M | 942.52%21.8M | 691.10%9.18M | 1,101.82%6.75M | -5.24%3.39M | -33.83%2.09M | 47.77%1.16M |
| Operating profit | -40.29%63.56M | -39.47%43.1M | -67.92%12.49M | 24.68%138.69M | 14.50%106.45M | 7.43%71.21M | 5.69%38.94M | -56.23%111.23M | -58.30%92.97M | -49.08%66.28M |
| Add:Non operating Income | -97.88%177.78 | ---- | --21.64K | -73.99%8.39K | 545.23%8.39K | -9.90%991.15 | --0 | 174.62%32.27K | -85.22%1.3K | 10.00%1.1K |
| Less:Non operating expense | 90.63%2.96M | -56.12%247.66K | 135.25%121.85K | -63.71%1.43M | -33.11%1.55M | 15.87%564.41K | -81.92%51.79K | 245.16%3.93M | 62.49%2.32M | 24.64%487.13K |
| Total profit | -42.23%60.61M | -39.34%42.86M | -68.14%12.39M | 27.89%137.27M | 15.73%104.9M | 7.37%70.65M | 6.37%38.89M | -57.58%107.33M | -59.08%90.65M | -49.30%65.8M |
| Less:Income tax cost | -46.34%8.37M | -44.59%5.88M | -69.62%1.71M | 42.44%19.34M | 11.46%15.6M | 9.99%10.61M | 4.49%5.64M | -63.30%13.58M | -62.09%13.99M | -55.95%9.65M |
| Net profit | -41.51%52.24M | -38.41%36.98M | -67.88%10.68M | 25.79%117.93M | 16.50%89.31M | 6.92%60.03M | 6.70%33.25M | -56.60%93.75M | -58.48%76.65M | -47.95%56.15M |
| Net profit from continuing operation | -41.51%52.24M | -38.41%36.98M | -67.88%10.68M | 25.79%117.93M | 16.50%89.31M | 6.92%60.03M | 6.70%33.25M | -56.60%93.75M | -58.48%76.65M | -47.95%56.15M |
| Less:Minority Profit | ---601.65 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net profit of parent company owners | -41.51%52.24M | -38.41%36.98M | -67.88%10.68M | 25.79%117.93M | 16.50%89.31M | 6.92%60.03M | 6.70%33.25M | -56.60%93.75M | -58.48%76.65M | -47.95%56.15M |
| Earning per share | ||||||||||
| Basic earning per share | -38.64%0.405 | -34.09%0.29 | -66.67%0.082 | 25.72%0.875 | 15.99%0.66 | 4.76%0.44 | 6.49%0.246 | -65.65%0.696 | -68.87%0.569 | -60.75%0.42 |
| Diluted earning per share | -38.64%0.405 | -34.09%0.29 | -67.07%0.081 | 24.57%0.867 | 15.99%0.66 | 4.76%0.44 | 6.49%0.246 | -65.65%0.696 | -68.87%0.569 | -60.75%0.42 |
| Other composite income | ||||||||||
| Total composite income | -41.51%52.24M | -38.41%36.98M | -67.88%10.68M | 25.79%117.93M | 16.50%89.31M | 6.92%60.03M | 6.70%33.25M | -56.60%93.75M | -58.48%76.65M | -47.95%56.15M |
| Total composite income of parent company owners | -41.51%52.24M | -38.41%36.98M | -67.88%10.68M | 25.79%117.93M | 16.50%89.31M | 6.92%60.03M | 6.70%33.25M | -56.60%93.75M | -58.48%76.65M | -47.95%56.15M |
| Total composite income of minority owners | ---601.65 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
